Stay updated on HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Sign up to get notified when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The study record now presents detailed information about the completed HIV and tuberculosis-prevention trial, including its treatment groups, safety and pharmacokinetic assessments, eligibility criteria, and related publications.
    Difference
    53%
    Check dated 2026-11-07T12:28:53.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.2 to v3.8.0 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T13:17:41.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A banner announces changes to NIH website terminology, including the use of “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-24T14:56:36.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The site’s footer revision identifier changed from v3.7.1 to v3.7.2 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-17T14:42:22.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:50:43.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the study record, with the 403 header and a site footer visible, indicating the trial details are inaccessible at this time.
    Difference
    19%
    Check dated 2026-09-19T19:13:35.000Z thumbnail image

Stay in the know with updates to HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HIV+ Safety of High-dose Rifapentine-Isoniazid DDI Clinical Trial page.